Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the National Cancer Plan will include measures to improve cancer research capacity in hospitals in the North of England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Research is crucial in tackling cancer, which is why the Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR). Cancer is a major area of NIHR spending at £141.6 million in 2024/25, reflecting its high priority. Research is a key focus of the National Cancer Plan. The plan will seek to ensure advances in cancer research benefit patients across the country, including the North of England.
The Department is committed to funding health and care research via the NIHR across England, to ensure that the research we support is inclusive and representative of the populations we serve.
NIHR research infrastructure has national coverage across the whole of England across all geographies and settings. Our infrastructure schemes aim to build research capacity and capability across the country across all geographies and settings. In line with prior commitments, the Department has increased funding for research infrastructure schemes delivering cancer research in northern regions, including Biomedical Research Centres, Clinical Research Facilities, and HealthTech Research Centres.
Through the NIHR Research Delivery Network, the NIHR provides funding and support to the National Health Service and other providers to deliver research, operating across 12 regions throughout the country. The North West, North East and North Cumbria, and Yorkshire and Humber Regional Research Delivery Networks operate in all NHS trusts that span the north of England, giving researchers and delivery teams the practical support they need locally so that more research can take place, and more people can take part.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of NHS policies on private access for patients with Postural Orthostatic Tachycardia Syndrome seeking faster access to specialist care.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.
Asked by: Helen Morgan (Liberal Democrat - North Shropshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of not extending Start for Life funding to new Best Start for Life Family Hub areas on the delivery of integrated early-years services by local authorities.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Delivering integrated, joined-up health, education, and family support is at the heart of our ambition to raise the healthiest generation of children ever.
Healthy Babies, formerly Start for Life, funding is helping families during the critical 1,001 days, and parents have said that they are more confident in feeding their babies and have better perinatal mental health because of this support. Further information is available at the following link:
We continue to assess how we can best support early years service integration across the country and remain committed to working with delivery partners locally to achieve this.
Healthy Babies is one element of our broader commitment to supporting babies, children, and families. From April 2026, Best Start Family Hubs will expand to every single local authority, backed by over £500 million, to reach up to half a million more children and families. This funding will help all local authorities to integrate a range of statutory and non-statutory child health and family services.
Best Start Family Hubs will form part of the architecture of the Neighbourhood Health Service. Through the shifts from hospital to community and from treatment to prevention, we will further strengthen the integration of services, helping to ensure that babies and their families can get the support they need, when and where they need it.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to involve cancer charities in the delivery and governance of the forthcoming National Cancer Plan.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Cancer Plan will build on the shift from hospital to community set out by the 10-Year Health Plan and will seek to foster improved collaboration with the voluntary and community sector to deliver this.
Governance mechanisms for monitoring implementation and ensuring accountability for delivery will be established as part of the development of the National Cancer Plan, which will be published in the new year.
Asked by: Gregory Stafford (Conservative - Farnham and Bordon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans her Department has to improve training and clinical awareness of Ehlers–Danlos syndrome among GPs and primary care clinicians to support earlier recognition and referral.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that Ehlers-Danlos syndromes (EDS) are complex, multi-systemic conditions that can be challenging to diagnose. While no formal assessment of average diagnosis times has been made, the Department is aware that many patients experience significant delays for a confirmed diagnosis. These delays are primarily due to low awareness among clinicians, the absence of a single diagnostic test for hypermobile EDS, and the need for multidisciplinary input.
For rarer genetically confirmed types of EDS, NHS England commissions a national diagnostic service. In addition to investigating and diagnosing complex and rare EDS types, the national diagnostic service supports general practitioners (GPs) and specialists in secondary and tertiary care by issuing detailed reports with management recommendations, developing guidelines and pathways of care, and offering clinician-to-clinician advice. It helps GPs by clarifying referral pathways and guiding ongoing care, while supporting hospital specialists through access to genetic testing, multidisciplinary input, and best practice guidance. This collaboration ensures accurate diagnosis, reduces unnecessary investigations, and promotes coordinated care across all levels of the health system, helping to avoid inappropriate referrals and ensuring that patients are able to access the correct specialist care efficiently.
We also recognise that GPs can find it challenging to diagnose EDS because these conditions share symptoms with many other disorders. The EDS GP Toolkit, developed by the Royal College of General Practitioners in partnership with Ehlers-Danlos Support UK, helps GPs in managing EDS by improving recognition, diagnosis, and management of these multi-system disorders. The toolkit aims to reduce delays in diagnosis and helps to prevent long-term disability through appropriate early management.
The Department is engaging with patient organisations to identify further opportunities to streamline referral processes and ensure equitable access to assessment and care.
Asked by: Gregory Stafford (Conservative - Farnham and Bordon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce the time taken for (a) referrals and (b) assessments for Ehlers-Danlos syndrome.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that Ehlers-Danlos syndromes (EDS) are complex, multi-systemic conditions that can be challenging to diagnose. While no formal assessment of average diagnosis times has been made, the Department is aware that many patients experience significant delays for a confirmed diagnosis. These delays are primarily due to low awareness among clinicians, the absence of a single diagnostic test for hypermobile EDS, and the need for multidisciplinary input.
For rarer genetically confirmed types of EDS, NHS England commissions a national diagnostic service. In addition to investigating and diagnosing complex and rare EDS types, the national diagnostic service supports general practitioners (GPs) and specialists in secondary and tertiary care by issuing detailed reports with management recommendations, developing guidelines and pathways of care, and offering clinician-to-clinician advice. It helps GPs by clarifying referral pathways and guiding ongoing care, while supporting hospital specialists through access to genetic testing, multidisciplinary input, and best practice guidance. This collaboration ensures accurate diagnosis, reduces unnecessary investigations, and promotes coordinated care across all levels of the health system, helping to avoid inappropriate referrals and ensuring that patients are able to access the correct specialist care efficiently.
We also recognise that GPs can find it challenging to diagnose EDS because these conditions share symptoms with many other disorders. The EDS GP Toolkit, developed by the Royal College of General Practitioners in partnership with Ehlers-Danlos Support UK, helps GPs in managing EDS by improving recognition, diagnosis, and management of these multi-system disorders. The toolkit aims to reduce delays in diagnosis and helps to prevent long-term disability through appropriate early management.
The Department is engaging with patient organisations to identify further opportunities to streamline referral processes and ensure equitable access to assessment and care.
Asked by: Gregory Stafford (Conservative - Farnham and Bordon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of NHS waiting times for the diagnosis of Ehlers–Danlos syndrome.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that Ehlers-Danlos syndromes (EDS) are complex, multi-systemic conditions that can be challenging to diagnose. While no formal assessment of average diagnosis times has been made, the Department is aware that many patients experience significant delays for a confirmed diagnosis. These delays are primarily due to low awareness among clinicians, the absence of a single diagnostic test for hypermobile EDS, and the need for multidisciplinary input.
For rarer genetically confirmed types of EDS, NHS England commissions a national diagnostic service. In addition to investigating and diagnosing complex and rare EDS types, the national diagnostic service supports general practitioners (GPs) and specialists in secondary and tertiary care by issuing detailed reports with management recommendations, developing guidelines and pathways of care, and offering clinician-to-clinician advice. It helps GPs by clarifying referral pathways and guiding ongoing care, while supporting hospital specialists through access to genetic testing, multidisciplinary input, and best practice guidance. This collaboration ensures accurate diagnosis, reduces unnecessary investigations, and promotes coordinated care across all levels of the health system, helping to avoid inappropriate referrals and ensuring that patients are able to access the correct specialist care efficiently.
We also recognise that GPs can find it challenging to diagnose EDS because these conditions share symptoms with many other disorders. The EDS GP Toolkit, developed by the Royal College of General Practitioners in partnership with Ehlers-Danlos Support UK, helps GPs in managing EDS by improving recognition, diagnosis, and management of these multi-system disorders. The toolkit aims to reduce delays in diagnosis and helps to prevent long-term disability through appropriate early management.
The Department is engaging with patient organisations to identify further opportunities to streamline referral processes and ensure equitable access to assessment and care.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much money is allocated to providing illegal migrants with (a) dental and (b) health care.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department and NHS England do not hold the information requested. The overall management of asylum seekers including provision of health and dental health care is a matter for the Home Office.
All asylum seeker accommodation providers have a duty and requirement to assist people who need it to access healthcare.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to specialist care for patients with Postural Orthostatic Tachycardia Syndrome, including reducing waiting times to see clinicians with relevant expertise.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the adequacy of NHS referral pathways for patients with Postural Orthostatic Tachycardia Syndrome, including the coordination of care between cardiology and neurology services.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.